Lantheus Medical Imaging, Inc. v. Zurich American Ins. Co.

255 F. Supp. 3d 443, 2015 U.S. Dist. LEXIS 55538
CourtDistrict Court, S.D. New York
DecidedApril 28, 2015
DocketNo. 10 Civ. 9371(KPF)
StatusPublished
Cited by23 cases

This text of 255 F. Supp. 3d 443 (Lantheus Medical Imaging, Inc. v. Zurich American Ins. Co.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lantheus Medical Imaging, Inc. v. Zurich American Ins. Co., 255 F. Supp. 3d 443, 2015 U.S. Dist. LEXIS 55538 (S.D.N.Y. 2015).

Opinion

REDACTED OPINION AND ORDER

KATHERINE POLK FAILLA, District Judge:

Plaintiff Lantheus Medical Imaging, Inc. (“Lantheus”) initiated this action against [445]*445Zurich American Insurance Company (“Zurich”) on December 16, 2010.- The lawsuit challenges Zurich’s denial of coverage, under a commercial property insurance policy purchased by Lantheus, for business income loss related to a 15-month shutdown of the nuclear reactor at Chalk River Laboratories in Ontario, Canada (the “NRU Reactor”). The NRU Reactor supplied a radioactive isotope used in Lan-theus’s diagnostic medical imaging products, and Lantheus alleges that it incurred more than $70 million in losses as a result of the shutdown. Zurich contends that Lantheus’s losses are not covered under the policy because (i) Lantheus did not experience a total cessation of business activity, and (ii) the shutdown was caused in whole or in part by the excluded peril of corrosion. Zurich now moves for summary judgment on these two grounds. For the reasons set forth in this Opinion, Zurich’s motion is granted.

BACKGROUND1

A. Factual Background

1. Lantheus and the NRU Reactor

Lantheus is a specialty pharmaceutical company that manufactures and distributes, among other things, diagiostic medical imaging products. (Def. 56.1 ¶ Í). Molybdenum-99 (“Moly-99”), a radioactive isotope resulting from the fission of uranium-235 in a nuclear reactor, is a key component in one of Lantheus’s products, the TechneLite Generator. (Id. at ¶ 2). , Prior to May 2009, Lantheus obtained Moly-99 from Nordion, Inc. (“Nordion”), which, in turn was supplied by the NRU Reactor. (Id. at ¶ 4). The NRU Reactor is operated by Atomic Energy of Canada Limited (“AECL”). (Id. at if 6). As of May 2009, the NRU Reactor supplied approximately 40% of the world’s medical isotopes. (Id. at ¶ 5).

2. The Policy

Zurich- issued to Lantheus an all-risk property insurance policy (the “Policy”)2 that was in effect from January 8, 2009, through January 8, 2010. (Def. 56.1 .¶ 23). Of particular relevance to the instant motion, the Policy covers Lantheus’s “Contingent Business Income Loss” (“CBI”) according to the following specifications:

We will pay for the actual Business Income Loss you sustain and necessary Extra Expense-you'incur resulting from the necessary suspension of ytiur business activities occurring at á premises described in the Declarations Schedule if the suspension is caused by direct physical loss of or damage caused by a covered cause of loss to a Contingent Property (of the type insured) -not owned, occupied, leased or rented by you or [446]*446insured.under this Policy and that .property is. located within th.e Covered Territory. We'Will pay no more than the . applicable sub-limit of insurance.

(Silverberg Decl., Ex. G at 28 (emphasis added)). Lantheus’s Billerica, Massachusetts facility where TechneLite Generators are produced (the “Billerica Facility”) is one of the premises described in the Declarations Schedule. "(Id. at 18).

The Policy defines “Contingent Property” to include “[a] property from which you or others on your account receive the delivery of manufactured materials or services if those materials or services are essential for the continuation of your business activities.” (Silverberg Decl., Ex. G at 28). Endorsement 6, in' turn, amends the Policy to provide a $70 million sub-limit- of insurance for “Contingent Time Element f[ro]m [AECL] — Chalk-River Reactor as a supplier of ... Nordion.” (Id. at 76).3 “Extra Expenses” are covered under the CBI provision beginning on the date of the loss, and. continuing “during the period of restoration to resume and continue as nearly as practicable your normal business activities at [the] premises[.]” (Id. at 28).

' The Policy distinguishes betwéen “covered” causes of loss and “excluded” causes of loss. “Covered Cause of Loss” is defined broadly, to include “all risks of direct physical loss of or damage (including machinery breakdown) from, any external cause unless excluded.” (Silverberg Deck, Ex. G at 50). Conversely, exclusions are detailed in “Causes of Loss Not Covered,” with corrosion being the exclusion relevant to the instant dispute: ,

We will not pay for loss or damage resulting from any of the following; such loss- or damages is excluded regardless of any cause or event that contributes concurrently or in any sequence to the loss or damage, except as specifically provided.
[[Image here]]
5. Developing, Latent and Other Causes The effects or cause of:
⅜ * *
b. Deterioration, depletion, rust, corrosion, erosion, loss of weight, evaporation^] or wear and tear[.]
[[Image here]]
’ But' if any of these results in a covered cause of loss, this exclusion does not apply' to the loss or damage caused by the covered cause of loss.

(Id. at 24-25 (emphasis added)). The' corrosion exclusion is bookended by two provisions that bear separate mention. First, the Policy contains a so-called “anti-concurrent cause” provision, which bars coverage where a claimed loss is caused by a combination of covered and excluded perils. Second, the Policy contains an “ensuing loss” exception, which provides coverage if an excluded peril causes a second, covered .peril to. occur; in that eventuality, coverage is provided only for the loss or damage that proximately results from the covered peril.

3. The Structure of the NRU Reactor and the Weakening of the Vessel Wall

The NRU Reactor consists of a cylindrical aluminum alloy reactor vessel and light water reflector, uranium fuel rods, and a [447]*447cooling system. (Pl. 56.1 ¶ 36). The light water reflector surrounds the reactor vessel, and a gas-filled space of about six inches, called an “annulus,” separates the two. (Id. at ¶¶ 37-38). Within the reactor vessel, uranium undergoes nuclear fission, producing up to 135 megawatts of mechanical power in the form of heat. (Id, at ¶ 45). Pumps, ordinarily powered by the electrical grid, drive “heavy water” through the vessel and into a series of heat exchangers to cool the uranium fuel rods. (Id. at ¶¶ 39-43).4

As of May 2009, the wall separating the annulus and reactor vessel was weakening (or thinning) to varying degrees in several places. The parties agree on this fact, but disagree on the types and causes of this weakening; for purposes of this motion, the Court will focus on the Plaintiff’s account of the weakening. (See Pl. 56.1 ¶¶ 47-53). The first manner of weakening is referred to by both parties as corrosion, and, solely to avoid confusion, the Court will use Plaintiffs term for this form of thinning: “General Corrosion.” (Id. at ¶ 53; see also St. Pierre Deck, Ex. 1 at 11 (describing the “general slow corrosion rate thinning of the reactor vessel on the annulus side”)). This General Corrosion caused solids to accumulate near the base of the annulus. (Pl. 56.1 ¶ 53; see also St. Pierre Deck, Ex.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
255 F. Supp. 3d 443, 2015 U.S. Dist. LEXIS 55538, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lantheus-medical-imaging-inc-v-zurich-american-ins-co-nysd-2015.